(Q38190532)

30 August 2017

1 reference

title

Treatment of the chronic hepatitis B virus carrier state (English)

1 reference

30 August 2017

1 reference

1 reference

1 reference

Lever AM

1

1 reference

30 August 2017

language of work or name

1 reference

1 May 1988

1 reference

30 August 2017

1 reference

30 August 2017

volume

16

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

221-229

1 reference

Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Cellular immunity and hepatitis-associated, Australia antigen liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Homology between HBV-DNA and a sequence regulating the interferon-induced antiviral system: possible mechanism of persistent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

The spectrum of immunologic abnormalities and clinical findings in homosexually active men

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Antiviral therapy in hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Enhanced NK cell activity in mice injected with interferon and interferon inducers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Fatal complications of virus hepatitis in two patients with agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2888%2997508-1

7 January 2021

10.1016/S0163-4453(88)97508-1

Identifiers

DOI

1 reference

release_5apyohk3n5ca7aul6lrxgv7c5y

30 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5apyohk3n5ca7aul6lrxgv7c5y

24 November 2022

mapped directly with Wikidata item

1 reference